EUVIMEDEUVIMED entdecken
Open Access

COVID-19 vaccine coverage targets to inform reopening plans in a low incidence setting

Eamon Conway, Camelia R Walker, Christopher Baker, Michael J Lydeamore, Gerard E Ryan iD, Trish Campbell, Joel C Miller, Nic Rebuli, Max Yeung, Greg Kabashima, Nicholas Geard iD, James Wood und 5 weitere

Proceedings of the Royal Society B: Biological Sciences · 30.08.2023 · 290 (2005)

DOI: 10.1098/rspb.2023.1437 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the Royal Society B: Biological Sciences, online erschienen am 30.08.2023. Verfasst von Eamon Conway und 16 weiteren Autor:innen. Beteiligte Einrichtung: Population Health and Immunity Division, WEHI, Parkville 3052, Vic, Australia. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Australian Government Department of Health Office of Health Protection.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since the emergence of SARS-CoV-2 in 2019 through to mid-2021, much of the Australian population lived in a COVID-19-free environment. This followed the broadly successful implementation of a strong suppression strategy, including international border closures. With the availability of COVID-19 vaccines in early 2021, the national government sought to transition from a state of minimal incidence and strong suppression activities to one of high vaccine coverage and reduced restrictions but with still-manageable transmission. This transition is articulated in the national ‘re-opening’ plan released in July 2021. Here, we report on the dynamic modelling study that directly informed policies within the national re-opening plan including the identification of priority age groups for vaccination, target vaccine coverage thresholds and the anticipated requirements for continued public health measures—assuming circulation of the Delta SARS-CoV-2 variant. Our findings demonstrated that adult vaccine coverage needed to be at least 60% to minimize public health and clinical impacts following the establishment of community transmission. They also supported the need for continued application of test–trace–isolate–quarantine and social measures during the vaccine roll-out phase and beyond.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesCOVID-19AdultHumansSARS-CoV-2IncidenceAustralia

Stichwörter der Autor:innen

COVID-19SARS-CoV-2mathematical modellingpandemic responsepublic health policyvaccination strategy

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Population Health and Immunity Division, WEHI, Parkville 3052, Vic, Australia.
  • School of Mathematics and Statistics, The University of Melbourne, Melbourne, Victoria, Australia.
  • Melbourne Centre for Data Science, The University of Melbourne, Melbourne, Victoria, Australia.
  • Centre of Excellence for Biosecurity Risk Analysis, The University of Melbourne, Melbourne, Victoria, Australia.
  • Department of Econometrics and Business Statistics, Monash University, Clayton, Victoria, Australia.
  • Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.

ORCID-Profile: Gerard E Ryan, Nicholas Geard, James M McCaw, David J Price, Freya M Shearer

Förderung

  • Australian Government Department of Health Office of Health Protection

Zitieren

APA

Conway, E., Walker, C. R., Baker, C., Lydeamore, M. J., Ryan, G. E., Campbell, T., Miller, J. C., Rebuli, N., Yeung, M., Kabashima, G., Geard, N., Wood, J., McCaw, J. M., McVernon, J., Golding, N., Price, D. J., & Shearer, F. M. (2023). COVID-19 vaccine coverage targets to inform reopening plans in a low incidence setting. Proceedings of the Royal Society B: Biological Sciences, 290(2005). https://doi.org/10.1098/rspb.2023.1437

Vancouver

Conway E, Walker CR, Baker C, Lydeamore MJ, Ryan GE, Campbell T, et al. COVID-19 vaccine coverage targets to inform reopening plans in a low incidence setting. Proceedings of the Royal Society B: Biological Sciences. 2023;290(2005). doi:10.1098/rspb.2023.1437

BibTeX
@article{Conway2023,
  author = {Conway, Eamon and Walker, Camelia R and Baker, Christopher and Lydeamore, Michael J and Ryan, Gerard E and Campbell, Trish and Miller, Joel C and Rebuli, Nic and Yeung, Max and Kabashima, Greg and Geard, Nicholas and Wood, James and McCaw, James M and McVernon, Jodie and Golding, Nick and Price, David J and Shearer, Freya M},
  title = {COVID-19 vaccine coverage targets to inform reopening plans in a low incidence setting},
  journal = {Proceedings of the Royal Society B: Biological Sciences},
  year = {2023},
  volume = {290},
  number = {2005},
  doi = {10.1098/rspb.2023.1437}
}
Kostenlos starten →